AMPLIFICATION OF IMMUNOLOGICAL FUNCTIONS BY SUBCUTANEOUS INJECTION OF INTERMEDIATE-HIGH DOSE INTERLEUKIN-2 FOR 2 YEARS AFTER AUTOLOGOUS STEM CELL TRANSPLANTATION IN CHILDREN WITH STAGE IV NEUROBLASTOMA.

MLA

Toren, Amos, et al. “Amplification of Immunological Functions by Subcutaneous Injection of Intermediate-High Dose Interleukin-2 for 2 Years After Autologous Stem Cell Transplantation in Children with Stage Iv Neuroblastoma.” Transplantation, vol. 70, no. 7, Oct. 2000, pp. 1100–04. EBSCOhost, https://doi.org/10.1097/00007890-200010150-00019.

APA

Toren, A., Nagler, A., Rozenfeld-Granot, G., Levanon, M., Davidson, J., Bielorai, B., Kaplinsky, C., Meitar, D., Mandel, M., Ackerstein, A., Ballin, A., Attias, D., Biniaminov, M., Rosenthal, E., Brok-Simoni, F., Rechavi, G., & Kaufmann, Y. (2000). Amplification of Immunological Functions by Subcutaneous Injection of Intermediate-High Dose Interleukin-2 for 2 Years After Autologous Stem Cell Transplantation in Children with Stage Iv Neuroblastoma. Transplantation, 70(7), 1100–1104. https://doi.org/10.1097/00007890-200010150-00019

Chicago

Toren, Amos, Arnon Nagler, Galit Rozenfeld-Granot, Michal Levanon, Jacqueline Davidson, Bella Bielorai, Chaim Kaplinsky, et al. 2000. “Amplification of Immunological Functions by Subcutaneous Injection of Intermediate-High Dose Interleukin-2 for 2 Years After Autologous Stem Cell Transplantation in Children with Stage Iv Neuroblastoma.” Transplantation 70 (7): 1100–1104. doi:10.1097/00007890-200010150-00019.